Healthcare Industry News: pulse oximetry
News Release - June 26, 2007
SunTech Medical Receives FDA Clearance for the SunTech 247(TM) Diagnostic Station
RESEARCH TRIANGLE PARK, N.C.--(HSMN NewsFeed)--SunTech Medical announced today that it has received clearance from the U.S. Food and Drug Administration (FDA) for the SunTech 247(TM) Diagnostic Station - a modular device that will provide manual and automated blood pressure as well as optional temperature and SpO2 measurements. The SunTech 247(TM) will launch into global distribution beginning in August.SunTech Medical, known for its popular Tango+ automated blood pressure monitor for exercise stress testing, has designed the SunTech 247(TM) as a clinical-grade BP device that bridges the gap between manual sphygmomanometers and vital signs devices.
"The SunTech 247(TM) Diagnostic Station is the first clinical grade product to offer automated BP measurement with a manual back-up mode, making it a very reliable BP device for healthcare providers," stated Dayn McBee, CEO. "Even the best oscillometric monitors may occasionally fail to get a BP reading. Now, however, we provide a simple way to get an accurate reading even in difficult measurement situations."
The SunTech 247(TM) is offered as an affordable replacement for mechanical blood pressure gauges. The modular plug-and-play (PnP) design allows the clinician to add additional temperature and pulse oximetry parameters at a later time, if needed. Flexible mounting systems include wall, table-top, and mobile stand configurations.
About SunTech Medical, Inc.
SunTech Medical, located in Research Triangle Park, N.C., is a world leader in motion-tolerant, non-invasive blood pressure monitoring products and technology. SunTech's product lines include 24-hour ambulatory BP monitoring devices, BP monitors for stress testing systems, and BP cuffs. The company supplies OEM BP technology to many of the world's leading monitor and defibrillator companies.
Source: SunTech Medical
Issuer of this News Release is solely responsible for its
content.
Please address inquiries directly to the issuing company.
